Journal of Medicinal Chemistry · 1990 · 93 citations · 0 references
Life SciencesMedicinal ChemistryPharmacologyMolecular PharmacologyNeurochemistryNeuropharmacologyAmino Acid NeurochemistryGlutamatergic NeurochemistryGlutamatergic PharmacologyNeuromodulationNeurotransmissionNeurotransmitter ReceptorsAntagonist ActivityGlutamate AntagonistsGlutamate Receptor AntagonismN-methyl-d-aspartate Receptor AntagonismNmda Receptor AntagonismNmda Receptor AntagonistsNmda ReceptorsPharmacology Of Glutamate Receptors
We report the synthesis of a series of 3-carboxy-, 3-(carboxymethyl)-, 3-(omega-phosphonoalkyl)-1-aminocyclobutane-1-carboxylic acids for evaluation as agonists or antagonists of neurotransmission at excitatory amino acid receptors, particularly N-methyl-D-aspartic acid (NMDA) receptors. The compounds were evaluated as agonists on their ability to depolarize the rat brain cortical wedge preparation or as antagonist of the actions of the selective agonists NMDA, quisqualic acid, and kainic acid. The chain-elongated glutamate derivatives with potential antagonist activity proved to be weak and frequently nonselective antagonists in this assay. The most noteworthy result was that trans isomer 7b was a very potent agonist, approximately 20 times more active than NMDA at NMDA receptors, while the cis isomer was 1/3 as potent as NMDA.